Contact Artificial Organs Market to Double by 2034, Reaching $70 Billion with 7.5% CAGR Growth | Exactitude Consultancy

Contact Artificial Organs Market Research Report (2025–2034)

Luton, Bedfordshire, United Kingdom, June 03, 2025 (GLOBE NEWSWIRE) -- The global artificial organs market is valued at around $35 billion in 2024 and is expected to grow to approximately $70 billion by 2034, exhibiting a strong CAGR of 7.5% over the forecast period. This growth is fueled by rising organ failure cases, technological innovations, and increasing acceptance of artificial organs as alternatives to transplantation.

Get a Sample PDF Brochure: https://exactitudeconsultancy.com/reports/65767/contact-artificial-organs-market#request-a-sample

Market Segmentation

By Product Type:

• Artificial Heart
• Artificial Kidney
• Artificial Pancreas
• Artificial Liver
• Artificial Limb

By Application:

• Ophthalmology
• Cardiology
• Audiology

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Homecare

By Technology:

• Mechanical
• Biological

By Distribution Channel:

• Direct Sales
• Online Sales
• Third-Party Distributors

Key Market Drivers

• Aging population and growing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and kidney failure.
• Technological advancements like 3D printing, biomaterials, and AI integration improving device customization, compatibility, and functionality.
• Rising healthcare expenditure and disposable incomes, especially in developing regions.
• Favorable regulatory environments accelerating approval of new devices.
• Growing patient and physician acceptance of artificial organs as viable alternatives to transplants.

Browse full Report - https://exactitudeconsultancy.com/reports/65767/contact-artificial-organs-market

Challenges

• Biocompatibility issues remain critical, risking organ rejection.
• Complex and time-consuming regulatory approvals.
• High development and manufacturing costs limiting smaller competitors.
• Potential supply chain disruptions affecting material availability.
• Pricing pressures from competitive markets and healthcare cost containment.

Growth Opportunities & Emerging Trends

• Expansion in regenerative medicine and tissue engineering research.
• Increased digital health integration (telemedicine, remote monitoring).
• Rising demand for wearable artificial organs for homecare.
• Strategic partnerships between biotech, medical device companies, and research institutions.
• Growth of the artificial pancreas market fueled by the diabetes epidemic.

Regional Market Analysis

North America

• Market Share: Approximately 45% of the global market.
• Growth Drivers:
  • Robust innovation ecosystem with significant R&D investments.
  • Highly advanced healthcare infrastructure and widespread access to cutting-edge medical technologies.
  • Aging population leading to increased demand for advanced medical devices and treatments.
  • Favorable regulatory environment with streamlined approval processes supporting faster product launches.
• Outlook: Sustained leadership position driven by continuous technological advancements and strong healthcare expenditure.

Europe

• Market Share: Around 30% of the global market.
• Growth Rate: Moderate growth with a CAGR of approximately 5.2%.
• Growth Drivers:
  • Strong government initiatives and funding focused on improving public healthcare systems.
  • Increasing adoption of innovative medical devices supported by regulatory harmonization across EU countries.
  • Aging population increasing demand for chronic disease management solutions.
• Outlook: Steady and consistent growth supported by policy frameworks promoting healthcare modernization.

Asia-Pacific

• Market Share: Rapidly expanding segment with the fastest growth rate at ~8.5% CAGR.
• Growth Drivers:
  • Rapid improvement in healthcare infrastructure, especially in urban centers.
  • Rising disposable incomes and growing awareness of advanced medical treatments.
  • Large patient populations in key markets like China and India fueling demand.
  • Expanding government healthcare programs and increased private sector participation.
• Outlook: Expected to close the gap with Western markets due to accelerating adoption of new technologies and expanding healthcare access.

Latin America & Middle East & Africa (MEA)

• Market Share: Emerging markets with smaller current shares but high potential.
• Challenges:
  • Economic instability and fluctuating currency values impacting healthcare investments.
  • Complex and evolving regulatory landscapes slowing product approvals.
  • Limited healthcare infrastructure in rural and underserved regions.
• Opportunities:
  • Increasing government initiatives to improve healthcare access.
  • Growing private healthcare sector and medical tourism in select countries.
• Outlook: Gradual growth expected as economic and regulatory challenges are addressed, unlocking significant market potential.

Buy Now : https://exactitudeconsultancy.com/purchase/?currency=USD&type=single_user_license&report_id=65767

Competitive Landscape

Leading companies include:

• Medtronic
• Abbott Laboratories
• Boston Scientific
• Edwards Lifesciences
• Siemens Healthineers
• Cardiac Technologies
• W.L. Gore & Associates
• Terumo Corporation
• Johnson & Johnson (Ethicon)
• B. Braun Melsungen AG
• Stryker Corporation
• Smith & Nephew
• Osiris Therapeutics
• Invivo Therapeutics
• SynCardia Systems

Recent Market Developments

1. Medtronic

Medtronic has made significant strides in diabetes management with the launch of the MiniMed™ 780G insulin pump system in September 2023. This system integrates continuous glucose monitoring (CGM) with an advanced insulin delivery algorithm, offering tighter glucose control and reduced hypoglycemia risk. In addition, the company has expanded its collaboration with Cosmo Pharmaceuticals to enhance gastrointestinal diagnostics using artificial intelligence, aiming to improve early detection and treatment outcomes.

2. Abbott Laboratories

In June 2023, Abbott entered a strategic partnership with iCardio.ai to integrate artificial intelligence into its cardiac imaging platforms. This collaboration enhances the precision and efficiency of cardiac diagnostics, enabling better patient outcomes. Additionally, Abbott completed the acquisition of Bigfoot Biomedical in September 2023, a move that bolsters its capabilities in developing advanced diabetes management solutions, including automated insulin delivery systems.

3. Boston Scientific

Boston Scientific has expanded its portfolio through the acquisition of a startup specializing in 3D bioprinting technology. This acquisition, announced in July 2023, positions the company at the forefront of regenerative medicine, enabling the development of bioengineered tissues and organs. The integration of 3D bioprinting capabilities is expected to revolutionize the field of artificial organs by allowing for the creation of patient-specific implants and prosthetics.

4. Siemens Healthineers

Siemens Healthineers unveiled several advanced diagnostic imaging solutions at the 2025 Asian Oceanian Congress of Radiology (AOCR). These include the MAGNETOM Flow 1.5T MRI system, which reduces helium usage and leverages AI for faster, more precise scans; the SOMATOM Pro.Pulse Dual Source CT scanner, designed for patients with high heart rates or limited breath-hold capacity; and the ACUSON Sequoia ultrasound system, which offers advanced tools for liver and musculoskeletal imaging. These innovations aim to enhance diagnostic accuracy and efficiency across diverse healthcare settings.

5. BICO Group

BICO Group, a leader in bioprinting and biotechnology, has expanded its capabilities through a €45 million investment by Sartorius, acquiring a 10% stake in the company. This partnership, announced in February 2025, focuses on research and development initiatives to advance digital solutions for cell line development workflows. The collaboration also includes distribution agreements in the Asia-Pacific region, aiming to accelerate BICO's growth and presence in the global market for 3D bioprinting technologies.

This report is also available in the following languages : Japanese (人工臓器市場へのお問い合わせ), Korean (인공장기시장에 문의하세요), Chinese (联系人造器官市场), French (Contacter le marché des organes artificiels), German (Kontakt Künstliche Organe Markt), and Italian (Contatta Artificial Organs Market), etc.

Get a Sample PDF Brochure: https://exactitudeconsultancy.com/reports/65767/contact-artificial-organs-market#request-a-sample

More Research Finding –

Artificial Organs and Bionics Market
The global artificial organs and bionics market is valued at approximately $40 billion in 2024, driven by advancements in biotechnology and increasing demand for organ transplants. The market is projected to reach around $85 billion by 2034, showcasing a robust Compound Annual Growth Rate (CAGR) of 8.1% during the forecast period (2025–2034).
https://exactitudeconsultancy.com/reports/62007/global-artificial-organs-and-bionics-market

Artificial Organs and Bionic Implants Market
The global market for artificial organs and bionic implants is projected to reach approximately $31 billion by 2024, driven by increasing demand for organ transplants and advances in technology. The market is expected to grow significantly, with a projected value of around $60 billion by 2034, reflecting a robust shift towards innovative healthcare solutions.
https://exactitudeconsultancy.com/reports/61997/global-artificial-organs-and-bionic-implants-market

Man-made Organ and Tissues Market
The global man-made organs and tissues market is anticipated to reach a valuation of approximately $40 billion in 2024. This burgeoning sector is projected to witness substantial growth, with an estimated market value of around $80 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of 7.2% over the forecast period from 2025 to 2034.
https://exactitudeconsultancy.com/reports/58069/global-man-made-organ-and-tissues-market

Artificial Organ and Tissues Market
The global artificial organs and tissues market is projected to reach a market value of approximately $36.2 billion in 2024, driven by advancements in biomaterials, increased organ transplant waiting lists, and a growing prevalence of chronic diseases. The sector is projected to witness significant growth, reaching an estimated $77.4 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of 8.1% during the forecast period from 2025 to 2034.
https://exactitudeconsultancy.com/reports/58055/global-artificial-organ-and-tissues-market

Constant Temperature Perfusion Device for Isolated Tissues and Organs Market
The global market for Constant Temperature Perfusion Devices for isolated tissues and organs was valued at approximately $410 million in 2024 and is projected to reach around $800 million by 2034. This indicates a compound annual growth rate (CAGR) of about 7.3% during the forecast period from 2025 to 2034.
https://exactitudeconsultancy.com/reports/56838/global-constant-temperature-perfusion-device-for-isolated-tissues-and-organs-market

3D Printed Surgical Model Market
The 3D printed surgical model market is valued at approximately $450 million in 2024, projected to reach nearly $1.2 billion by 2034. This growth anticipates a Compound Annual Growth Rate (CAGR) of around 10.1% between 2025 and 2034.
https://exactitudeconsultancy.com/reports/51200/3d-printed-surgical-model-market

Blood And Organ Bank Market
The global blood and organ bank market is valued at approximately $30 billion, demonstrating robust growth driven by increasing healthcare demands and advancements in medical technology. The projected market value for 2025 is expected to reach $32 billion, with a forecast of escalating to around $55 billion by 2034. This growth trajectory translates to a Compound Annual Growth Rate (CAGR) of about 6.5% during the forecast period from 2025 to 2034.
https://exactitudeconsultancy.com/reports/50992/blood-and-organ-bank-market

U.S. Tissue Banking Market
The U.S. tissue banking market is currently valued at approximately $4.5 billion in 2024. It is projected to reach around $7.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period from 2025 to 2034.
https://exactitudeconsultancy.com/reports/50321/u-s-tissue-banking-market

Organ On Chips Market
The organs-on-chips market is expected to grow at 30.76% CAGR from 2023 to 2030. It is expected to reach above USD 262.6 Million by 2030 from USD 40.18 million in 2023.
https://exactitudeconsultancy.com/reports/30456/organ-on-chips-market

Biopreservation Market
The Biopreservation Market is expected to grow at 8% CAGR from 2022 to 2029. It is expected to reach above USD 8.33 billion by 2029 from USD 3.9 billion in 2020.
https://exactitudeconsultancy.com/reports/16534/biopreservation-market

Testing, Inspection, and Certification Market
The global Testing, Inspection, and Certification (TIC) market is valued at approximately USD 260 billion in 2024, with an anticipated growth trajectory leading to a projected market value of around USD 400 billion by 2034. This reflects a Compound Annual Growth Rate (CAGR) of about 4.6% during the forecast period from 2025 to 2034.
https://exactitudeconsultancy.com/reports/65844/testing-inspection-and-certification-market

Healthcare Simulation Market
The global healthcare simulation market is valued at approximately $2.5 billion, driven by increasing demand for innovative training solutions within medical education and patient safety. The market is projected to reach around $5 billion by 2034, indicating a robust growth trajectory. This growth is supported by a Compound Annual Growth Rate (CAGR) of approximately 7.5% during the forecast period of 2025–2034.
https://exactitudeconsultancy.com/reports/65841/healthcare-simulation-market

Irfan Tamboli (Head of Sales)
Phone: + 1704 266 3234
Email: sales@exactitudeconsultancy.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.